Literature DB >> 29930151

Warfarin, a juggler's demise.

Laurent O Mosnier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29930151      PMCID： PMC6014355          DOI： 10.1182/blood-2018-05-843151

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase.

Authors:  Mark A Rishavy; Kevin W Hallgren; Lee Wilson; Savita Singh; Kurt W Runge; Kathleen L Berkner
Journal:  Blood       Date:  2018-03-28       Impact factor: 22.113

2.  Functional study of the vitamin K cycle in mammalian cells.

Authors:  Jian-Ke Tie; Da-Yun Jin; David L Straight; Darrel W Stafford
Journal:  Blood       Date:  2011-01-14       Impact factor: 22.113

3.  VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.

Authors:  Julie Lacombe; Mark A Rishavy; Kathleen L Berkner; Mathieu Ferron
Journal:  JCI Insight       Date:  2018-01-11

Review 4.  Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants.

Authors:  Noel C Chan; John W Eikelboom; Jeffrey I Weitz
Journal:  Circ Res       Date:  2016-04-29       Impact factor: 17.367

5.  Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.

Authors:  Simone Rost; Andreas Fregin; Vytautas Ivaskevicius; Ernst Conzelmann; Konstanze Hörtnagel; Hans-Joachim Pelz; Knut Lappegard; Erhard Seifried; Inge Scharrer; Edward G D Tuddenham; Clemens R Müller; Tim M Strom; Johannes Oldenburg
Journal:  Nature       Date:  2004-02-05       Impact factor: 49.962

6.  The vitamin K oxidoreductase is a multimer that efficiently reduces vitamin K epoxide to hydroquinone to allow vitamin K-dependent protein carboxylation.

Authors:  Mark A Rishavy; Kevin W Hallgren; Lee A Wilson; Aisulu Usubalieva; Kurt W Runge; Kathleen L Berkner
Journal:  J Biol Chem       Date:  2013-08-05       Impact factor: 5.157

7.  VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.

Authors:  Katrin J Czogalla; Kerstin Liphardt; Klara Höning; Veit Hornung; Arijit Biswas; Matthias Watzka; Johannes Oldenburg
Journal:  Blood Adv       Date:  2018-03-27

Review 8.  The vitamin K cycle.

Authors:  Johannes Oldenburg; Milka Marinova; Clemens Müller-Reible; Matthias Watzka
Journal:  Vitam Horm       Date:  2008       Impact factor: 3.421

Review 9.  Structural and functional insights into enzymes of the vitamin K cycle.

Authors:  J-K Tie; D W Stafford
Journal:  J Thromb Haemost       Date:  2016-01-29       Impact factor: 5.824

Review 10.  VKORC1: molecular target of coumarins.

Authors:  J Oldenburg; M Watzka; S Rost; C R Müller
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824
  10 in total
  1 in total

1.  Effect of rifampicin on anticoagulation of warfarin: A case report.

Authors:  Ya-Ni Hu; Bo-Ting Zhou; Hua-Rong Yang; Qi-Lin Peng; Xu-Rui Gu; Shu-Sen Sun
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.